Companies / Germany
Merck KGaA To Build Biopharmaceutical Plant
August 2006 | Company Finance AlertConfirming its commitment to the growing biotechnology sector, German firm Merck KGaA has decided to construct a biopharmaceutical production plant at its headquarters in Darmstadt, Germany. At an estimated cost of EUR190mn (US$244mn), the facility represents the second-largest single investment ever made by the company. Approximately 190 highly skilled employees will be recruited to operate the plant and construction is expected to commence in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
